ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Mohammad Ali Yousefnia
Mohammad Hossein Mandegar
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yousefnia, M. A.
Right arrow Articles by Amouzadeh, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yousefnia, M. A.
Right arrow Articles by Amouzadeh, F.
Related Collections
Right arrow Valve disease
Right arrowRelated Article

Ann Thorac Surg 2007;83:958-963
© 2007 The Society of Thoracic Surgeons

Original Articles: Cardiovascular

Papillary Muscle Repositioning in Mitral Valve Replacement in Patients With Left Ventricular Dysfunction

Mohammad Ali Yousefnia, MD, Mohammad Hossein Mandegar, MD, Farideh Roshanali, MD*, Farshid Alaeddini, MD, Farshad Amouzadeh, MA

Day General Hospital, Tehran, Iran

Accepted for publication August 28, 2006.

* Address correspondence to Dr Roshanali, 15th Tower, 8th Floor, No. 1, Hormozan St, Ghods Shahrak, Tehran 14466, Iran (Email: farideh_roshanali{at}yahoo.com).

Background: The aim of this study was to investigate the feasibility of performing papillary muscle repositioning for mitral valve replacement procedures in patients with left ventricular dysfunction and to determine the early and late effects of this procedure on clinical outcome and left ventricular mechanics.

Methods: One hundred patients with ejection fraction less than 40, who were candidates for isolated surgical correction of mitral insufficiency, had mitral valve replacement and were prospectively randomly assigned to either total chordal-sparing or papillary muscle repositioning. Fifty subjects underwent papillary muscle repositioning (PMR group), and the remaining 50 had complete preservation of all chordal structures with mitral valve replacement (CMVR group). Echocardiography was performed preoperatively, at discharge, and after 2 years to determine dimensions, left ventricular shape, and function.

Results: End-diastolic and -systolic volumes decreased in both groups initially and continued to decline. Decreasing volumes, however, were more significant in the PMR group, in which the significant decrease in the sphericity index continued for another 2 years. In contrast, the sphericity index in the CMVR group had no significant changes at discharge and at 2 years. In terms of systolic performance, ejection fraction had no significant changes in the CMVR group, whereas ejection fraction significantly increased in the PMR group.

Conclusions: Papillary muscle repositioning may result in more favorable left ventricular remodeling compared with complete retention of the mitral subvalvular apparatus during mitral valve replacement. It confers a significant early and late advantage by causing significant reductions in the left ventricular chamber volume, sphericity index, and systolic performance.


Related Article

Invited commentary
Donald Glower
Ann. Thorac. Surg. 2007 83: 963. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
D. Glower
Invited commentary
Ann. Thorac. Surg., March 1, 2007; 83(3): 963 - 963.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by The Society of Thoracic Surgeons.